Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Advanced Medical Equipment & Technology - NEC
- Sub-Industry: Health Care Equipment
- Symbol: NYSE:VAR
- CUSIP: 92220P10
- Web: www.varian.com
Capitalization:- Market Cap: $9.43 billion
- Outstanding Shares: 91,921,000
Average Prices:- 50 Day Moving Avg: $103.47
- 200 Day Moving Avg: $91.27
- 52 Week Range: $75.20 - $107.08
P/E:- Trailing P/E Ratio: 33.48
- Foreward P/E Ratio: 23.00
- P/E Growth: 2.65
Sales & Book Value:- Annual Revenue: $3.25 billion
- Price / Sales: 2.90
- Book Value: $14.04 per share
- Price / Book: 7.31
Profitability:- EBIDTA: $625.1 million
- Net Margins: 9.39%
- Return on Equity: 24.82%
- Return on Assets: 11.15%
Debt:- Debt-to-Equity Ratio: 0.21%
- Current Ratio: 1.52%
- Quick Ratio: 1.20%
Misc:- Average Volume: 914,760 shs.
- Beta: 0.62
- Short Ratio: 7.65
Frequently Asked Questions for Varian Medical Systems (NYSE:VAR)
What is Varian Medical Systems' stock symbol?
Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."
How were Varian Medical Systems' earnings last quarter?
Varian Medical Systems, Inc. (NYSE:VAR) announced its quarterly earnings results on Wednesday, July, 26th. The company reported $1.04 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.94 by $0.10. The firm earned $662.40 million during the quarter, compared to the consensus estimate of $663.86 million. Varian Medical Systems had a return on equity of 24.82% and a net margin of 9.39%. The firm's quarterly revenue was up 3.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.00 earnings per share. View Varian Medical Systems' Earnings History.
What guidance has Varian Medical Systems issued on next quarter's earnings?
Varian Medical Systems updated its fourth quarter earnings guidance on Wednesday, July, 26th. The company provided earnings per share guidance of $1.15-$1.23 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.18.
Where is Varian Medical Systems' stock going? Where will Varian Medical Systems' stock price be in 2017?
12 brokers have issued 1 year price targets for Varian Medical Systems' shares. Their forecasts range from $81.50 to $106.00. On average, they anticipate Varian Medical Systems' share price to reach $92.14 in the next twelve months. View Analyst Ratings for Varian Medical Systems.
What are analysts saying about Varian Medical Systems stock?
Here are some recent quotes from research analysts about Varian Medical Systems stock:
- 1. According to Zacks Investment Research, "Varian Medical's oncology and Proton therapy business growth prospects remain impressive. The company is addressing both the tier 1 and mid-tier markets through its Edge, Truebeam and VitalBeam, Halcyon products. Varian has been winning contracts, not only in the Americas but also in the emerging international markets, which is a huge positive. We believe China and Africa present significant top-line growth opportunity in the near term. The company is opening up new offices in Africa and the Middle East, which shows that it is aware of the growth opportunities in the region. Varian Medical posted an impressive second quarter of fiscal 2017, beating the Zacks Consensus Estimate on both the counts. The company’s upbeat guidance for the coming quarters is a positive. Share price movement in the past three months has been encouraging, trading above the broader industry." (7/13/2017)
- 2. Jefferies Group LLC analysts commented, "We hosted VAR CEO and CFO for a lunch. Key takeaways: 1) VREX spin process was all inclusive; 2) F17 RemainCo outlook calls for HSD EPS growth; 3) RadOnc outlook stable on multiple fronts near and long-term; 3) next-gen linac expected in 2H17; 5) aim is to double Software in 5-years; 6) proton stable postCTCL with glimmers of light in tunnel; and 7) at least $1.0bn in debt capacity for M&A. We are publishing revised stand-alone estimates and PT of $88." (2/8/2017)
Who are some of Varian Medical Systems' key competitors?
Some companies that are related to Varian Medical Systems include Waters Corporation (WAT), Hologic (HOLX), ResMed (RMD), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR), Accelerate Diagnostics (AXDX), Quidel Corporation (QDEL), Natus Medical Incorporated (BABY), ABAXIS (ABAX), Mazor Robotics (MZOR), Luminex Corporation (LMNX), GenMark Diagnostics (GNMK), LeMaitre Vascular (LMAT), Accuray Incorporated (ARAY), Corindus Vascular Robotics (CVRS) and Pacific Biosciences of California (PACB).
Who are Varian Medical Systems' key executives?
Varian Medical Systems' management team includes the folowing people:
- R. Andrew Eckert, Independent Chairman of the Board
- Dow R. Wilson, President, Chief Executive Officer
- Timothy E. Guertin, Vice Chairman of the Board
- Elisha W. Finney, Chief Financial Officer, Executive Vice President - Finance
- Gary E. Bischoping Jr., Chief Financial Officer
- Kolleen T. Kennedy, Executive Vice President and President - Oncology Systems
- John W. Kuo, Senior Vice President, General Counsel, Corporate Secretary
- Rafael Torres, Senior Vice President - Business Development and Strategy
- Jose Baselga M.D., Ph.D., Director
- Jean-Luc Butel, Director
Who owns Varian Medical Systems stock?
Varian Medical Systems' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Alecta Pensionsforsakring Omsesidigt (3.09%), APG Asset Management N.V. (0.88%), Russell Investments Group Ltd. (0.72%), Acadian Asset Management LLC (0.36%), Oakbrook Investments LLC (0.35%) and BB&T Corp (0.22%). Company insiders that own Varian Medical Systems stock include Clarence R Verhoef, Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Mark R Laret, R Andrew Eckert, Ruediger Naumann-Etienne, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.
Who sold Varian Medical Systems stock? Who is selling Varian Medical Systems stock?
Varian Medical Systems' stock was sold by a variety of institutional investors in the last quarter, including Marathon Asset Management LLP, APG Asset Management N.V., Cape Cod Five Cents Savings Bank, Acadian Asset Management LLC, Smithbridge Asset Management Inc. DE, DnB Asset Management AS, BB&T Corp and Strs Ohio. Company insiders that have sold Varian Medical Systems stock in the last year include Clarence R Verhoef, Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Mark R Laret, Susan L Bostrom and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.
Who bought Varian Medical Systems stock? Who is buying Varian Medical Systems stock?
Varian Medical Systems' stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Oakbrook Investments LLC, Personal Capital Advisors Corp, Mn Services Vermogensbeheer B.V., Bedrijfstakpensioenfonds Voor DE Media PNO, Bank of Montreal Can, Aperio Group LLC and BTIM Corp.. View Insider Buying and Selling for Varian Medical Systems.
How do I buy Varian Medical Systems stock?
Shares of Varian Medical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Varian Medical Systems' stock price today?
One share of Varian Medical Systems stock can currently be purchased for approximately $102.59.
MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Varian Medical Systems (NYSE:VAR) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 3 Sell Ratings, 5 Hold Ratings, 4 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.08) |
| Consensus Price Target: | $92.14 (10.19% downside) |
Analysts' Ratings History for Varian Medical Systems (NYSE:VAR)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/14/2017 | Robert W. Baird | Reiterated Rating | Neutral | $89.00 -> $99.00 | Low |  |
| 5/17/2017 | Aegis | Reiterated Rating | Hold | $91.00 | Low | |
| 5/16/2017 | Goldman Sachs Group, Inc. (The) | Initiated Coverage | Neutral -> Neutral | $92.00 | Low | |
| 5/15/2017 | Citigroup Inc. | Upgrade | Neutral -> Buy | | Low | |
| 5/11/2017 | Jefferies Group LLC | Reiterated Rating | Buy | | Low | |
| 5/8/2017 | BTIG Research | Upgrade | Neutral -> Buy | $106.00 | High | |
| 4/27/2017 | Barrington Research | Downgrade | Outperform -> Market Perform | | High | |
| 4/27/2017 | Royal Bank Of Canada | Boost Price Target | Sector Perform -> Sector Perform | $82.00 -> $90.00 | High | |
| 4/24/2017 | Off Wall Street | Initiated Coverage | Sell | | Low | |
| 1/26/2017 | Evercore ISI | Downgrade | Hold -> Sell | $81.50 | N/A | |
| 7/28/2016 | Morgan Stanley | Boost Price Target | Underweight | $80.00 -> $86.00 | N/A | |
| 7/28/2016 | Brean Capital | Boost Price Target | Buy | $87.00 -> $90.00 | N/A | |
| 10/20/2015 | J P Morgan Chase & Co | Reiterated Rating | Neutral | $95.00 -> $75.00 | N/A | |
(Data available from 7/27/2015 forward)
Earnings History for Varian Medical Systems (NYSE:VAR)Earnings History by Quarter for Varian Medical Systems (NYSE VAR)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/26/2017 | Q3 2017 | $0.94 | $1.04 | $663.86 million | $662.40 million | View | N/A | |
| 4/26/2017 | Q2 2017 | $0.88 | $0.89 | $639.26 million | $655.00 million | View | N/A | |
| 10/26/2016 | Q4112 | $1.34 | $1.38 | $880.29 million | $912.00 million | View | Listen | |
| 7/27/2016 | Q316 | $1.17 | $1.22 | $779.90 million | $789.40 million | View | Listen | |
| 4/27/2016 | Q216 | $1.08 | $1.09 | $769.56 million | $758.80 million | View | Listen | |
| 1/27/2016 | Q116 | $0.94 | $0.99 | $748.01 million | $757.00 million | View | Listen | |
| 10/28/2015 | Q4 | $1.10 | $1.04 | $813.18 million | $817.80 million | View | Listen | |
| 7/29/2015 | Q3 | $1.10 | $1.13 | $810.41 million | $784.00 million | View | Listen | |
| 4/29/2015 | Q215 | $1.00 | $1.05 | $799.66 million | $759.40 million | View | N/A | |
| 1/28/2015 | Q115 | $0.87 | $0.99 | $720.83 million | $737.90 million | View | N/A | |
| 10/22/2014 | Q415 | $1.21 | $1.02 | $837.86 million | $812.10 million | View | Listen | |
| 7/23/2014 | Q314 | $1.09 | $1.08 | $767.52 million | $747.70 million | View | N/A | |
| 4/23/2014 | Q4112 | $1.03 | $1.04 | $772.84 million | $779.00 million | View | N/A | |
| 1/22/2014 | Q3112 | $0.90 | $0.91 | $718.23 million | $712.00 million | View | N/A | |
| 10/23/2013 | Q3112 | $1.12 | $1.08 | $779.02 million | $770.00 million | View | N/A | |
| 7/24/2013 | Q3 2013 | $1.01 | $1.03 | $749.01 million | $726.20 million | View | N/A | |
| 4/24/2013 | Q2 2013 | $1.02 | $1.04 | $758.02 million | $768.40 million | View | N/A | |
| 1/23/2013 | Q1 2013 | $0.87 | $0.86 | $676.15 million | $678.40 million | View | N/A | |
| 10/25/2012 | | $1.03 | $1.08 | | | View | N/A | |
| 7/25/2012 | | $0.94 | $0.96 | | | View | N/A | |
| 4/25/2012 | | $0.96 | $0.96 | | | View | N/A | |
| 1/25/2012 | | $0.75 | $0.79 | | | View | N/A | |
| 10/27/2011 | | $0.97 | $0.95 | | | View | N/A | |
| 7/27/2011 | | $0.83 | $0.83 | | | View | N/A | |
| 4/27/2011 | | $0.85 | $0.86 | | | View | N/A | |
| 1/26/2011 | | $0.73 | $0.80 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Varian Medical Systems (NYSE:VAR)2017 EPS Consensus Estimate: $4.15
2018 EPS Consensus Estimate: $4.48
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $1.04 | $1.06 | $1.05 |
| Q2 2017 | 2 | $0.91 | $1.08 | $1.00 |
| Q3 2017 | 2 | $0.94 | $0.95 | $0.95 |
| Q4 2017 | 2 | $1.12 | $1.19 | $1.16 |
| Q1 2018 | 2 | $0.92 | $1.03 | $0.98 |
| Q2 2018 | 2 | $1.03 | $1.07 | $1.05 |
| Q3 2018 | 2 | $1.07 | $1.17 | $1.12 |
| Q4 2018 | 2 | $1.27 | $1.39 | $1.33 |
(Data provided by Zacks Investment Research)
Dividend History for Varian Medical Systems (NYSE:VAR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Varian Medical Systems (NYSE:VAR)Insider Ownership Percentage: 0.91%
Institutional Ownership Percentage: 99.52%
Insider Trades by Quarter for Varian Medical Systems (NYSE:VAR)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 7/13/2017 | John W Kuo | SVP | Sell | 1,597 | $104.43 | $166,774.71 | |
| 7/13/2017 | Kolleen T Kennedy | EVP | Sell | 2,021 | $104.73 | $211,659.33 | |
| 7/12/2017 | John W Kuo | SVP | Sell | 863 | $104.48 | $90,166.24 | |
| 7/12/2017 | Kolleen T Kennedy | EVP | Sell | 1,088 | $104.49 | $113,685.12 | |
| 7/10/2017 | Dow R Wilson | Insider | Sell | 15,060 | $103.37 | $1,556,752.20 | |
| 6/20/2017 | Kolleen T Kennedy | EVP | Sell | 26,092 | $105.00 | $2,739,660.00 | |
| 6/13/2017 | John W Kuo | SVP | Sell | 734 | $101.91 | $74,801.94 | |
| 6/12/2017 | John W Kuo | SVP | Sell | 863 | $101.25 | $87,378.75 | |
| 6/12/2017 | Kolleen T Kennedy | EVP | Sell | 1,087 | $101.20 | $110,004.40 | |
| 6/9/2017 | Timothy E Guertin | Director | Sell | 16,000 | $103.22 | $1,651,520.00 | |
| 6/8/2017 | Mark R Laret | Director | Sell | 1,428 | $103.47 | $147,755.16 | |
| 6/1/2017 | Kolleen T Kennedy | EVP | Sell | 56,573 | $99.76 | $5,643,722.48 | |
| 5/31/2017 | John W Kuo | SVP | Sell | 19,819 | $99.67 | $1,975,359.73 | |
| 5/12/2017 | John W Kuo | SVP | Sell | 862 | $96.39 | $83,088.18 | |
| 5/2/2017 | Susan L Bostrom | Director | Sell | 3,589 | $91.08 | $326,886.12 | |
| 4/12/2017 | John W Kuo | SVP | Sell | 864 | $89.74 | $77,535.36 | |
| 3/17/2017 | John W Kuo | SVP | Sell | 3,876 | $91.75 | $355,623.00 | |
| 3/13/2017 | John W Kuo | SVP | Sell | 862 | $87.89 | $75,761.18 | |
| 3/1/2017 | John W Kuo | SVP | Sell | 10,353 | $84.81 | $878,037.93 | |
| 1/5/2017 | Dow R Wilson | Insider | Sell | 13,334 | $88.74 | $1,183,259.16 | |
| 12/8/2016 | John W Kuo | SVP | Sell | 1,267 | $90.33 | $114,448.11 | |
| 12/5/2016 | Dow R Wilson | Insider | Sell | 10,000 | $90.03 | $900,300.00 | |
| 11/7/2016 | Dow R Wilson | Insider | Sell | 10,000 | $90.59 | $905,900.00 | |
| 10/31/2016 | Timothy E Guertin | Director | Sell | 4,000 | $90.32 | $361,280.00 | |
| 10/20/2016 | John W Kuo | SVP | Sell | 21,266 | $103.70 | $2,205,284.20 | |
| 10/5/2016 | Dow R Wilson | Insider | Sell | 10,000 | $99.44 | $994,400.00 | |
| 10/3/2016 | Elisha W Finney | CFO | Sell | 4,668 | $98.87 | $461,525.16 | |
| 9/15/2016 | John W Kuo | SVP | Sell | 4,073 | $95.47 | $388,849.31 | |
| 9/7/2016 | Elisha W Finney | CFO | Sell | 9,000 | $96.95 | $872,550.00 | |
| 9/6/2016 | Dow R Wilson | Insider | Sell | 10,000 | $96.08 | $960,800.00 | |
| 9/1/2016 | Elisha W Finney | CFO | Sell | 2,000 | $95.82 | $191,640.00 | |
| 8/5/2016 | Dow R Wilson | Insider | Sell | 10,000 | $95.14 | $951,400.00 | |
| 8/1/2016 | Clarence R Verhoef | SVP | Sell | 9,483 | $94.88 | $899,747.04 | |
| 8/1/2016 | Elisha W Finney | CFO | Sell | 25,334 | $94.90 | $2,404,196.60 | |
| 8/1/2016 | Timothy E. Guertin | Director | Sell | 4,000 | $94.88 | $379,520.00 | |
| 7/5/2016 | Dow R Wilson | CEO | Sell | 10,000 | $82.08 | $820,800.00 | |
| 6/27/2016 | Dow R Wilson | CEO | Sell | 10,000 | $78.27 | $782,700.00 | |
| 6/8/2016 | Ruediger Naumann-Etienne | Director | Sell | 1,000 | $84.83 | $84,830.00 | |
| 6/3/2016 | Mark R Laret | Director | Sell | 1,545 | $83.48 | $128,976.60 | |
| 5/2/2016 | Timothy E. Guertin | Director | Sell | 4,000 | $81.55 | $326,200.00 | |
| 4/20/2016 | Elisha W Finney | CFO | Sell | 4,000 | $85.95 | $343,800.00 | |
| 4/18/2016 | Clarence R Verhoef | SVP | Sell | 2,500 | $85.00 | $212,500.00 | |
| 3/23/2016 | Dow R Wilson | CEO | Sell | 45,650 | $78.86 | $3,599,959.00 | |
| 3/10/2016 | Ruediger Naumann-Etienne | Director | Sell | 428 | $77.99 | $33,379.72 | |
| 3/7/2016 | Timothy E. Guertin | Director | Sell | 4,000 | $79.47 | $317,880.00 | |
| 2/17/2016 | Elisha W. Finney | CFO | Sell | 2,454 | $78.59 | $192,859.86 | |
| 12/7/2015 | Dow R. Wilson | CEO | Sell | 9,000 | $80.00 | $720,000.00 | |
| 12/2/2015 | R Andrew Eckert | Director | Sell | 3,000 | $81.67 | $245,010.00 | |
| 11/24/2015 | Elisha W. Finney | CFO | Sell | 2,334 | $80.90 | $188,820.60 | |
| 11/6/2015 | Dow R. Wilson | CEO | Sell | 18,000 | $80.26 | $1,444,680.00 | |
| 9/8/2015 | Dow R. Wilson | CEO | Sell | 9,000 | $80.05 | $720,450.00 | |
| 7/6/2015 | Dow R Wilson | CEO | Sell | 9,000 | $85.80 | $772,200.00 | |
| 7/2/2015 | Elisha W Finney | CFO | Sell | 2,000 | $85.95 | $171,900.00 | |
| 7/1/2015 | Timothy E Guertin | Director | Sell | 25,000 | $84.20 | $2,105,000.00 | |
| 6/5/2015 | Dow R Wilson | CEO | Sell | 9,000 | $86.29 | $776,610.00 | |
| 6/1/2015 | Elisha W Finney | CFO | Sell | 2,000 | $85.99 | $171,980.00 | |
| 6/1/2015 | Timothy E Guertin | Director | Sell | 25,000 | $86.08 | $2,152,000.00 | |
| 5/6/2015 | Dow R Wilson | CEO | Sell | 9,000 | $86.64 | $779,760.00 | |
| 4/17/2015 | Dow R Wilson | CEO | Sell | 18,760 | $93.63 | $1,756,498.80 | |
| 4/1/2015 | Elisha W Finney | CFO | Sell | 5,000 | $92.76 | $463,800.00 | |
| 4/1/2015 | Timothy E Guertin | Director | Sell | 25,000 | $92.76 | $2,319,000.00 | |
| 3/20/2015 | Dow R Wilson | CEO | Sell | 18,759 | $94.44 | $1,771,599.96 | |
| 3/16/2015 | Kolleen T Kennedy | EVP | Sell | 1,972 | $95.00 | $187,340.00 | |
| 3/6/2015 | Timothy E Guertin | Director | Sell | 4,000 | $93.50 | $374,000.00 | |
| 3/2/2015 | Elisha W Finney | CFO | Sell | 5,000 | $93.44 | $467,200.00 | |
| 3/2/2015 | Timothy E Guertin | Director | Sell | 50,000 | $93.48 | $4,674,000.00 | |
| 2/23/2015 | Elisha W Finney | CFO | Sell | 1,326 | $92.97 | $123,278.22 | |
| 2/10/2015 | Mark R Laret | Director | Sell | 10,000 | $92.32 | $923,200.00 | |
| 2/3/2015 | Venkatraman Thyagarajan | Director | Sell | 10,000 | $92.71 | $927,100.00 | |
| 2/2/2015 | Dow R Wilson | CEO | Sell | 60,000 | $91.78 | $5,506,800.00 | |
| 2/2/2015 | Elisha W Finney | CFO | Sell | 6,667 | $91.79 | $611,963.93 | |
| 2/2/2015 | John W Kuo | SVP | Sell | 3,490 | $92.04 | $321,219.60 | |
| 2/2/2015 | Ruediger Naumann-Etienne | Director | Sell | 10,000 | $91.87 | $918,700.00 | |
| 1/5/2015 | Timothy E Guertin | Director | Sell | 50,000 | $86.27 | $4,313,500.00 | |
| 1/2/2015 | Elisha W Finney | CFO | Sell | 15,000 | $87.05 | $1,305,750.00 | |
| 12/11/2014 | Timothy E Guertin | Director | Sell | 105,000 | $86.67 | $9,100,350.00 | |
| 12/1/2014 | Elisha W Finney | CFO | Sell | 21,000 | $88.72 | $1,863,120.00 | |
| 11/24/2014 | Elisha W Finney | CFO | Sell | 2,930 | $88.24 | $258,543.20 | |
| 11/17/2014 | Elisha W Finney | CFO | Sell | 1,837 | $87.71 | $161,123.27 | |
| 11/11/2014 | Kolleen T Kennedy | SVP | Sell | 1,242 | $85.79 | $106,551.18 | |
| 11/10/2014 | Ruediger Naumann-Etienne | Director | Sell | 5,000 | $85.31 | $426,550.00 | |
| 11/3/2014 | Elisha W Finney | CFO | Sell | 25,000 | $83.82 | $2,095,500.00 | |
| 11/3/2014 | Timothy E Guertin | Director | Sell | 80,000 | $83.72 | $6,697,600.00 | |
| 10/29/2014 | Elisha W Finney | CFO | Sell | 10,000 | $83.95 | $839,500.00 | |
| 10/27/2014 | Kolleen T Kennedy | SVP | Sell | 1,240 | $81.00 | $100,440.00 | |
| 10/1/2014 | Elisha W Finney | CFO | Sell | 15,000 | $79.98 | $1,199,700.00 | |
| 9/11/2014 | John W Kuo | SVP | Sell | 605 | $85.82 | $51,921.10 | |
| 9/2/2014 | Elisha W Finney | CFO | Sell | 20,000 | $85.18 | $1,703,600.00 | |
| 8/20/2014 | Venkatraman Thyagarajan | Director | Sell | 5,000 | $84.25 | $421,250.00 | |
| 8/7/2014 | Elisha W Finney | CFO | Sell | 5,000 | $83.95 | $419,750.00 | |
| 8/1/2014 | Elisha W Finney | CFO | Sell | 15,000 | $81.66 | $1,224,900.00 | |
| 8/1/2014 | Timothy E Guertin | Director | Sell | 80,000 | $81.69 | $6,535,200.00 | |
| 7/9/2014 | John W Kuo | SVP | Sell | 582 | $85.00 | $49,470.00 | |
| 7/1/2014 | Elisha W Finney | CFO | Sell | 20,000 | $83.86 | $1,677,200.00 | |
| 6/23/2014 | John W Kuo | SVP | Sell | 1,745 | $85.00 | $148,325.00 | |
| 6/16/2014 | Kolleen T Kennedy | SVP | Sell | 1,416 | $82.42 | $116,706.72 | |
| 6/2/2014 | Elisha W Finney | CFO | Sell | 10,000 | $82.35 | $823,500.00 | |
| 5/12/2014 | Kolleen Kennedy | SVP | Sell | 1,417 | $81.96 | $116,137.32 | |
| 5/1/2014 | Elisha Finney | CFO | Sell | 10,000 | $78.99 | $789,900.00 | |
| 5/1/2014 | Timothy Guertin | Director | Sell | 80,000 | $78.98 | $6,318,400.00 | |
| 4/11/2014 | Kolleen T Kennedy | SVP | Sell | 640 | $72.15 | $46,176.00 | |
| 4/1/2014 | Elisha Finney | CFO | Sell | 10,000 | $83.97 | $839,700.00 | |
| 3/17/2014 | Clarence Verhoef | SVP | Sell | 1,140 | $84.70 | $96,558.00 | |
| 3/11/2014 | Kolleen Kennedy | SVP | Sell | 1,417 | $84.39 | $119,580.63 | |
| 3/10/2014 | Timothy Guertin | Director | Sell | 80,000 | $84.05 | $6,724,000.00 | |
| 3/3/2014 | Elisha Finney | CFO | Sell | 10,000 | $83.41 | $834,100.00 | |
| 2/21/2014 | Mark Laret | Director | Sell | 1,411 | $84.06 | $118,608.66 | |
| 2/11/2014 | Kolleen Kennedy | SVP | Sell | 1,416 | $80.59 | $114,115.44 | |
| 2/10/2014 | R Andrew Eckert | Director | Sell | 5,887 | $80.52 | $474,021.24 | |
| 2/3/2014 | Elisha Finney | CFO | Sell | 10,000 | $79.34 | $793,400.00 | |
| 2/3/2014 | Timothy Guertin | Director | Sell | 27,000 | $79.34 | $2,142,180.00 | |
| 1/31/2014 | Susan Bostrom | Director | Sell | 18,900 | $81.50 | $1,540,350.00 | |
| 1/2/2014 | Elisha Finney | CFO | Sell | 24,321 | $77.69 | $1,889,498.49 | |
| 1/2/2014 | Richard Levy | Director | Sell | 20,000 | $77.68 | $1,553,600.00 | |
| 12/30/2013 | John Kuo | SVP | Sell | 3,027 | $77.08 | $233,321.16 | |
| 12/23/2013 | Clarence Verhoef | SVP | Sell | 1,297 | $76.13 | $98,740.61 | |
| 12/9/2013 | Dow Wilson | CEO | Sell | 95,000 | $79.09 | $7,513,550.00 | |
| 12/4/2013 | Robert Kluge | SVP | Sell | 12,932 | $80.00 | $1,034,560.00 | |
| 12/2/2013 | Elisha Finney | CFO | Sell | 10,000 | $79.04 | $790,400.00 | |
| 12/2/2013 | Richard Levy | Director | Sell | 20,000 | $79.04 | $1,580,800.00 | |
| 12/2/2013 | Robert Kluge | SVP | Sell | 9,889 | $79.00 | $781,231.00 | |
| 11/29/2013 | Kolleen Kennedy | SVP | Sell | 9,307 | $78.00 | $725,946.00 | |
| 11/25/2013 | Kolleen Kennedy | SVP | Sell | 2,972 | $75.49 | $224,356.28 | |
| 11/22/2013 | Elisha Finney | CFO | Sell | 1,617 | $74.83 | $121,000.11 | |
| 11/14/2013 | Elisha Finney | CFO | Sell | 5,000 | $74.95 | $374,750.00 | |
| 11/1/2013 | Elisha W Finney | CFO | Sell | 5,000 | $72.27 | $361,350.00 | |
| 11/1/2013 | Richard M Levy | Director | Sell | 20,000 | $72.27 | $1,445,400.00 | |
| 10/14/2013 | Robert Kluge | SVP | Sell | 13,889 | $78.00 | $1,083,342.00 | |
| 10/10/2013 | Robert Kluge | SVP | Sell | 13,871 | $77.00 | $1,068,067.00 | |
| 9/20/2013 | Kolleen Kennedy | SVP | Sell | 1,247 | $76.00 | $94,772.00 | |
| 9/16/2013 | Elisha Finney | CFO | Sell | 16,334 | $74.95 | $1,224,233.30 | |
| 9/16/2013 | Kolleen Kennedy | SVP | Sell | 2,562 | $75.00 | $192,150.00 | |
| 9/11/2013 | Elisha W Finney | CFO | Sell | 23,666 | $74.95 | $1,773,766.70 | |
| 9/3/2013 | Elisha Finney | CFO | Sell | 5,000 | $70.95 | $354,750.00 | |
| 9/3/2013 | Richard Levy | Director | Sell | 20,000 | $70.95 | $1,419,000.00 | |
| 8/8/2013 | Kolleen Kennedy | SVP | Sell | 2,400 | $73.50 | $176,400.00 | |
| 8/1/2013 | Elisha W Finney | CFO | Sell | 5,000 | $72.81 | $364,050.00 | |
| 8/1/2013 | R Andrew Eckert | Director | Sell | 1,375 | $72.93 | $100,278.75 | |
| 7/19/2013 | John W Kuo | SVP | Sell | 1,817 | $72.00 | $130,824.00 | |
| 7/17/2013 | Richard M Levy | Director | Sell | 20,000 | $70.00 | $1,400,000.00 | |
| 7/16/2013 | Elisha W Finney | CFO | Sell | 5,000 | $69.95 | $349,750.00 | |
| 6/17/2013 | Elisha W Finney | CFO | Sell | 5,000 | $69.95 | $349,750.00 | |
| 6/17/2013 | Richard M Levy | Director | Sell | 20,000 | $70.00 | $1,400,000.00 | |
| 6/10/2013 | Timothy E Guertin | Director | Sell | 27,000 | $68.81 | $1,857,870.00 | |
| 5/21/2013 | Elisha W Finney | CFO | Sell | 2,313 | $69.86 | $161,586.18 | |
| 5/14/2013 | Elisha W Finney | CFO | Sell | 5,000 | $69.95 | $349,750.00 | |
| 5/14/2013 | John W Kuo | SVP | Sell | 1,112 | $70.00 | $77,840.00 | |
| 5/14/2013 | Richard M Levy | Director | Sell | 20,000 | $70.00 | $1,400,000.00 | |
| 2/14/2013 | John W Kuo | SVP | Sell | 1,111 | $71.05 | $78,936.55 | |
| 9/4/2012 | Kolleen T Kennedy | SVP | Sell | 1,900 | $64.00 | $121,600.00 | |
| 8/20/2012 | Elisha W Finney | CFO | Sell | 4,000 | $59.95 | $239,800.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Varian Medical Systems (NYSE:VAR)
Latest Headlines for Varian Medical Systems (NYSE:VAR)
| Source: |
|
| Date | Headline |
|---|
 | Varian Medical Systems, Inc. (NYSE:VAR) Releases Quarterly Earnings Results
www.americanbankingnews.com - July 26 at 9:56 PM |
| Varian Medical Systems, Inc. (NYSE:VAR) Issues Q4 Earnings Guidance
www.americanbankingnews.com - July 26 at 6:34 PM |
 | Varian to Showcase Latest Radiotherapy and Radiosurgery Technologies and Software at AAPM 2017
finance.yahoo.com - July 26 at 9:39 AM |
| Varian to Showcase Latest Radiotherapy and Radiosurgery Technologies and Software at AAPM 2017
finance.yahoo.com - July 26 at 9:39 AM |
| Varian Medical Systems, Inc. (VAR) Rating Lowered to Buy at BidaskClub
www.americanbankingnews.com - July 24 at 7:14 PM |
| Varian Medical Systems, Inc. (NYSE:VAR) Expected to Post Quarterly Sales of $663.22 Million
www.americanbankingnews.com - July 21 at 7:56 PM |
 | Varian Medical (VAR) Q3 Earnings: Is a Surprise in Store? - Nasdaq
www.nasdaq.com - July 21 at 8:24 AM |
| Varian Medical (VAR) Q3 Earnings: Is a Surprise in Store?
finance.yahoo.com - July 21 at 8:24 AM |
| Analysts Expect Varian Medical Systems, Inc. (VAR) Will Post Earnings of $0.94 Per Share
www.americanbankingnews.com - July 19 at 11:34 AM |
| Varian Medical Systems, Inc. (VAR) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - July 19 at 9:15 AM |
| Varian Medical Systems, Inc. (VAR) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - July 18 at 10:35 PM |
| Varian Eclipse Users Generate Highest Scoring Plans in International Treatment Plan Competition
finance.yahoo.com - July 18 at 9:37 AM |
| Varian Medical Systems, Inc. (NYSE:VAR) Given "Neutral" Rating at Robert W. Baird
www.americanbankingnews.com - July 15 at 8:28 PM |
| Varian Medical Systems, Inc. (NYSE:VAR) SVP John W. Kuo Sells 863 Shares
www.americanbankingnews.com - July 14 at 8:46 PM |
| Insider Selling: Varian Medical Systems, Inc. (NYSE:VAR) EVP Sells 1,088 Shares of Stock
www.americanbankingnews.com - July 14 at 8:46 PM |
 | Form 4 VARIAN MEDICAL SYSTEMS For: Jul 12 Filed by: KUO JOHN W
www.streetinsider.com - July 14 at 9:40 AM |
| Insider Selling: Varian Medical Systems, Inc. (NYSE:VAR) SVP Sells 1,597 Shares of Stock
www.americanbankingnews.com - July 13 at 10:53 PM |
| Kolleen T. Kennedy Sells 2,021 Shares of Varian Medical Systems, Inc. (VAR) Stock
www.americanbankingnews.com - July 13 at 10:53 PM |
| Varian Medical Systems, Inc. (NYSE:VAR) Upgraded to "Strong-Buy" at BidaskClub
www.americanbankingnews.com - July 13 at 10:20 PM |
| Zacks Investment Research Lowers Varian Medical Systems, Inc. (VAR) to Hold
www.americanbankingnews.com - July 13 at 8:51 AM |
| Varian Medical Systems, Inc. (VAR) Insider Sells $1,556,752.20 in Stock
www.americanbankingnews.com - July 11 at 10:52 PM |
| Leading Cancer Center Commences Advanced Treatments Using Varian Edge™ Radiosurgery System
finance.yahoo.com - July 11 at 9:07 AM |
| Phibro Animal Health & Zydus Cadila Plan to Expand in India - Nasdaq
www.nasdaq.com - July 8 at 4:01 PM |
| Here's Why You Should Add Abbott Laboratories Right Now - Nasdaq
www.nasdaq.com - July 6 at 4:05 PM |
| Here's Why You Should Add Abbott Laboratories Right Now
finance.yahoo.com - July 6 at 4:05 PM |
| Analysts’ Recommendations for Varian Medical Systems
finance.yahoo.com - July 4 at 8:29 AM |
| Varian Medical Systems: Analyzing Its Stock Performance
finance.yahoo.com - July 4 at 8:29 AM |
| Varian Medical Systems Gets New Product Approval
finance.yahoo.com - July 3 at 8:06 AM |
 | Concord Medical To Install Proton Therapy System at Guangzhou Concord Cancer Hospital - PR Newswire (press release)
www.prnewswire.com - July 1 at 8:44 AM |
| Varian Medical Systems Receives FDA 510(k) Clearance for Halcyon Treatment System
finance.yahoo.com - June 29 at 4:08 PM |
| Varian Medical Systems, Inc. (VAR) Downgraded by BidaskClub to Buy
www.americanbankingnews.com - June 29 at 3:08 PM |
| Varian Medical Systems, Inc. (VAR) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - June 27 at 1:36 PM |
| Varian Medical Systems Schedules Third Quarter FY2017 News Release and Conference Call
finance.yahoo.com - June 26 at 3:24 PM |
| $663.22 Million in Sales Expected for Varian Medical Systems, Inc. (VAR) This Quarter
www.americanbankingnews.com - June 25 at 1:02 PM |
| Varian Medical Systems, Inc. (VAR) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - June 23 at 8:46 PM |
| Zacks: Analysts Expect Varian Medical Systems, Inc. (VAR) Will Post Earnings of $0.94 Per Share
www.americanbankingnews.com - June 23 at 11:27 AM |
| Varian Medical Systems, Inc. (VAR) Raised to Strong-Buy at BidaskClub
www.americanbankingnews.com - June 22 at 3:32 PM |
| Varian Works with Sify Technologies to Host Data Remotely Across CTSI Network of Cancer Centers in India
finance.yahoo.com - June 22 at 2:30 PM |
| Major Milestone for UK's First High Energy Proton Therapy Center with Varian Cyclotron Installation
finance.yahoo.com - June 22 at 2:30 PM |
| Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 26,092 Shares of Stock
www.americanbankingnews.com - June 21 at 7:24 PM |
| ETFs with exposure to Varian Medical Systems, Inc. : June 19, 2017
finance.yahoo.com - June 20 at 9:02 AM |
| Varian and National Centre for Particle Therapy in Denmark Attain Milestone with Successful Cyclotron Installation
finance.yahoo.com - June 20 at 9:02 AM |
| Varian Showcases Halcyon System at DEGRO Meet, Stock Up - Nasdaq
www.nasdaq.com - June 17 at 7:02 AM |
| Varian Medical Systems, Inc. :VAR-US: Earnings Analysis: Q2, 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 17 at 7:02 AM |
| Varian Spotlights New Halcyon Radiotherapy Treatment System at DEGRO 2017
finance.yahoo.com - June 15 at 3:44 PM |
| John W. Kuo Sells 734 Shares of Varian Medical Systems, Inc. (VAR) Stock
www.americanbankingnews.com - June 14 at 10:48 PM |
| BidaskClub Downgrades Varian Medical Systems, Inc. (VAR) to Buy
www.americanbankingnews.com - June 14 at 3:32 PM |
| Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 1,087 Shares of Stock
www.americanbankingnews.com - June 13 at 10:32 PM |
| Varian Medical Systems, Inc. (VAR) SVP Sells $87,378.75 in Stock
www.americanbankingnews.com - June 13 at 10:32 PM |
| Varian Medical Systems, Inc. (VAR) Director Sells $1,651,520.00 in Stock
www.americanbankingnews.com - June 12 at 10:32 PM |
Varian Medical Systems (VAR) Chart for Thursday, July, 27, 2017
